PLRX – pliant therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference
Pliant Therapeutics (NASDAQ:PLRX) was upgraded by analysts at Wall Stree
Form SCHEDULE 13G PLIANT THERAPEUTICS, Filed by: CITADEL ADVISORS LLC
Form SCHEDULE 13G PLIANT THERAPEUTICS, Filed by: CITADEL ADVISORS LLC
Form 4 PLIANT THERAPEUTICS, For: Jan 22 Filed by: Kuo Minnie
Form 4 PLIANT THERAPEUTICS, For: Jan 22 Filed by: Cummings Keith Lamont
Form 4 PLIANT THERAPEUTICS, For: Jan 22 Filed by: Cheung Lily
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.